ISBN-13: 9783639147803 / Angielski / Miękka / 2009 / 172 str.
For many years iron chelators have been used for thetreatment of iron overload disease and cancer.Nonetheless, the development of novel syntheticchelators with improved bioavaliability and reducedcytotoxicity remains an area of much interest. Thisthesis is an examination of some mechanisms throughwhich iron binding agents cause toxicity. Two novelclasses of iron chelator were compared to clinicallyrelevant chelators with a range of cytotoxicprofiles. A variety of assays were employed tocategorise these agents in terms of their capacity towithdraw iron from cells, to generate oxygen radicalsand to damage to DNA. In correlating these propertieswith in vitro effects on proliferation it emergesthat toxicity of iron chelators arises from cellulariron deprivation, the induction of oxidative stressand biomolecular localisation of oxygen radicals. In identifying functional structural elements andiron binding motifs this work indicates biologicalconsequences to be considered in the design of ironbinding chemotherapeutic agents.